Status:
UNKNOWN
Real World App-based CCAAP Management of Children With Asthma
Lead Sponsor:
Beijing Children's Hospital
Collaborating Sponsors:
Capital Institute of Pediatrics, China
Centers for Disease Control and Prevention, China
Conditions:
Asthma
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
This study is a multi-center randomized controlled trial of children with asthma. The objective of the study is to compare the App-based efficacy of China Children Asthma Action Plan (CCAAP) and writt...
Detailed Description
The study is a multi-center randomized control study.The enrollment period is 3 months. Patients who is in 6-17 years of age will be randomized recruited into two groups: the App-based asthma action p...
Eligibility Criteria
Inclusion
- did not receive control treatment or did not reach well-control;
- can perform spirometry pulmonary function tests;
- parents are skilled in using smartphones and APP apps (Android or IOS);
Exclusion
- reach the level of asthma well control;
- can not use the smartphone APP software;
- can not cooperate the test of peak expiratory flow;
- did not treatment coexist respiratory disease effectively (such as sinusitis, obstructive sleep apnea-hypopnea syndrome, etc.);
- combined with other systemic diseases outside the respiratory system (such as leukemia, rheumatoid arthritis, etc.).
- receiving allergen-specific immunotherapy.
- undergoing trial for other medications or instruments.
Key Trial Info
Start Date :
November 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06112405
Start Date
November 25 2023
End Date
December 31 2024
Last Update
November 1 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.